Nanoparticle-albumin-bound (nab®) paclitaxel combines a protein with a chemotherapeutic agent in the particle form and can be delivered without the use of these synthetic solvents and is approved for the treatment of metastatic breast cancer [2], advanced non-small cell lung cancer (NSCLC) [3], and late stage pancreatic cancer [3]. The gene discussed is ALB; the disease is non-small cell lung carcinoma.